Kelly D. Kaita
Winnipeg, MB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Barriers to Hepatitis B Treatment: A Multicentre Cross-Sectional Registry and Survey Study by the Canadian Hepatitis B Network.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 01, 2026
A hepatology hero rides off into the sunset: A tribute to Dr Gerald Minuk.
Journal: Canadian liver journal
Published: February 23, 2026
Trends in hepatitis C care in Canada's provincial and territorial prisons from 2020 to 2024.
Journal: Canadian liver journal
Published: June 13, 2025
Annual trends of hepatitis C virus infection in Manitoba between 1998 and 2018: A focus on special populations.
Journal: Canadian liver journal
Published: October 21, 2022
Disparities in hepatitis C care across Canadian provincial prisons: Implications for hepatitis C micro-elimination.
Journal: Canadian liver journal
Published: November 13, 2020
Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network.
Journal: CMAJ open
Published: October 24, 2019
Spontaneous Flares of Chronic Hepatitis B Virus in Hepatitis Be Antigen Negative Carriers Who Subsequently Clear Hepatitis B Surface Antigen.
Journal: Digestive diseases and sciences
Published: September 26, 2019
Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 21, 2019
Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials.
Journal: The lancet. Gastroenterology & hepatology
Published: October 30, 2018
Circulating and inducible IL-32α in chronic hepatitis C virus infection.
Journal: Canadian liver journal
Published: March 22, 2018
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.
Journal: The New England journal of medicine
Published: January 25, 2018
Concomitant nonalcoholic fatty liver disease does not alter the activity, severity or course of primary biliary cholangitis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 07, 2017
Last Updated: 09/26/2026